Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COREG MR vs Atenolol vs Lisinopril for LVH Regression
NCT00108082Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2005
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of carvedilol in hypertension (HTN) and left ventricular hypertrophy (LVH) (3 arms), sponsored by GSK. Primary endpoint: Change in Left Ventricular Mass Indexed by Body Surface Area (MRI) at 12 months. Started Jan 2005; status: completed.
02
Drugs
carvedilol
03
Conditions
hypertension (HTN)left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT00108082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108082.